TEVANAC

This brand name is authorized in Nigeria.

Active ingredients

The drug TEVANAC contains one active pharmaceutical ingredient (API):

1	Nepafenac UNII 0J9L7J6V8C - NEPAFENAC
	Nepafenac is a non-steroidal anti-inflammatory and analgesic prodrug. After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Amfenac inhibits the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production.
	Read more about Nepafenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9607	Eye drops	Tevanac Ophthalmic Solution SOL_DROPS 1% w/v 1 x 5 mL (in HDPE bottle)	Eye Drops Light yellow suspension free from any type of visible foreign particles TEVANAC OPHTHALMIC SOLUTION EYE DROPS. NEPAFENAC 0.1% W/V EYE DROPS NEPAFENAC 0.1% W/V B4-9607 Drugs SENSORY ORGANS Imported Products 5ML Prescription Only Medicine (POM) 25/01/2024 PHARMACY PLUS LIMITED, 18, MOJIDI STREET, OFF TOYIN STREET, IKEJA-LAGOS. 19501142 info@pharplusltd.com STALLION LAB PVT LTD AT INDIANA OPHTHALMICS, 136, 137 G.I.D.C. ESTATE, WADHWANCITY. 363035. GUJARAT. INDIA , India	30/01/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC10	Nepafenac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9607